Patients with calculus of gallbladder candidated for laparoscopic cholecystectomy. Calculus of gallbladder without cholecystitis
Conditions
Interventions
Intervention 1: Intervention group 1: Receiving Pre-treatment regimens of one oral tablet of tapentadol 75 mg (NUCYNTA) branded by Collegium Pharmaceutical, Inc., an hour before surgery, with naproxe
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with cholelithiasis undergoing elective laparoscopic cholecystectomy Physical status 1 or 2 according to the classification of the American Association of Anesthesiologists
Exclusion criteria
Exclusion criteria: Sensitivity to tapontadol or oxycodone History of chronic consumption of other opioids or analgesics Cardiac, liver, respiratory or renal disease Surgeries for over one and a half hours Complicated surgeries
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Measuring the pain intensity at the beginning of the study (after surgery) and every two hours after the operation for up to 12 hours. Method of measurement: Visual analogue scale.;First request for pain medication. Timepoint: From the beginning of the study (after surgery) up to 12 hours after surgery. Method of measurement: Check patient records.;Amount of pain medication within 12 hours after surgery. Timepoint: From the beginning of the study (after surgery) up to 12 hours after surgery. Method of measurement: Check patient records.;Pain duration. Timepoint: From the beginning of the study (after surgery) up to 12 hours after surgery. Method of measurement: Self-declaration. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDawood Aghamohammadi
Tabriz University of Medical Sciences
Outcome results
None listed